New Precision Medicine Program to Study Role of Genomics in Disease

New Precision Medicine Program to Study Role of Genomics in Disease

Publication date: Feb 14, 2020

February 13, 2020 – The National Human Genome Research Institute (NHGRI) has announced that it will establish a new precision medicine and genomics program within its Division of Intramural Research.

-This effort is about establishing a highly interactive group of researchers who will focus on using genomics and informatics to improve healthcare outcomes,” said Leslie Biesecker, MD, chief of the NHGRI Medical Genomics and Metabolic Genetics Branch and the new program’s director.

With the establishment of the NHGRI precision medicine program, the NIH Clinical Center will provide unique and unprecedented opportunities to study individuals identified through the new informatics approaches.

The establishment of the new precision medicine program will add to NHGRI’s many efforts to advance the use of genomics in research and healthcare.

-The new NHGRI precision health research program is well-positioned to capitalize on a confluence of developments related to the growing availability of genomic and medical data cohort-based studies,” said Green.

Concepts Keywords
Biobanks Eric D. Green
Cancer Human Genome Project
Cohort Francis Collins
Confluence Branches of biology
Critical Mass Life sciences
Eric Green Biology
Genetic Tumors
Genomic Medicine Healthcare
Healthcare Efforts healthcare
Healthcare Industry Healthcare outcomes
Informatics Informatics tools


Type Source Name
disease MESH diagnosis
disease MESH growth
drug DRUGBANK Etodolac
disease MESH tumors


Leave a Comment

Your email address will not be published. Required fields are marked *